grade I and II internal hemorrhoids.
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: The intervention group includes 60 men and women with first and second degree hemorrhoids, referring to medical centers in Tabriz city, who will
Sponsors
Applied Pharmaceutical Research Center, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
17 Years to 70 Years
Inclusion criteria
Inclusion criteria: Clients with first and second grade hemorrhoids who have been diagnosed with clinical symptoms and confirmation from a general surgeon. Patients should be in the age group of 17 to 70 years. Hemorrhoids of the clients are not caused by systemic diseases such as hypertension. Presence of hemorrhoid symptoms for at least more than 6 days Ability to read and write
Exclusion criteria
Exclusion criteria: Use of systemic steroidal and non-steroidal anti-inflammatory drugs and analgesic treatments The use of systemic steroidal and non-steroidal anti-inflammatory drugs and analgesic and anti-hemorrhoid treatments (for one month before the study) and the use of anticoagulant drugs. The need for a surgical method to treat hemorrhoids (with the approval of a gastroenterologist and using clinical and colonoscopy tests) Patients with problems such as anorectal abscess, fistula, tuberculosis, herpes, varicella (confirmed by clinical tests or colonoscopy) Infectious inflammatory diseases of the digestive tract or colorectal cancer (according to the patient's statement) Previous use of laser or use of phlebotonic medicine to treat hemorrhoids one week before entering the study (according to the patient's statement) Participation in another interventional study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigating the amount of pain with the colo-rectal clinical treatment evaluation questionnaire. Timepoint: This questionnaire will be completed once before the start of the study and then in the first, second and fourth weeks, and once after the end of the intervention, in the eighth week after the start of the treatment. Method of measurement: (CORECTS= Colo-Rectal Evaluation of Clinical Therapeutics Scale).;Investigating the amount of itching around the anus with the colorectal clinical treatment evaluation questionnaire. Timepoint: This questionnaire will be completed once before the start of the study and then in the first, second and fourth weeks, and once after the end of the intervention, in the eighth week after the start of the treatment. Method of measurement: (CORECTS= Colo-Rectal Evaluation of Clinical Therapeutics Scale).;Investigating the amount of bleeding with the colo-rectal clinical treatment evaluation questionnaire. Timepoint: This questionnaire will be completed once before the start of the study and then in the first, second and fourth weeks, and once after the end of the intervention, in the eighth week after the start of the treatment. Method of measurement: (CORECTS= Colo-Rectal Evaluation of Clinical Therapeutics Scale). | — |
Secondary
| Measure | Time frame |
|---|---|
| The questionnaire (WHOQOL-BREF) will be used to measure the quality of life. Timepoint: This questionnaire will be completed before the start of the study, in the fourth week after the intervention and in the eighth week after the start of the treatment. Method of measurement: Questionnaire (WHOQOL-BREF). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBabak Abri Aghdam
Tabriz University of Medical Sciences
Outcome results
None listed